Waldenström Macroglobulinemia (WM)
9 clinical trials · Condition
◉ Watch Waldenström Macroglobulinemia (WM)
| Record | Firm | Date |
|---|---|---|
| A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies (NCT05131022) | Nurix Therapeutics, Inc. | 2022-04-13 |
| A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies (NCT04830137) | Nurix Therapeutics, Inc. | 2021-05-05 |
| Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors (NCT03771157) | University of Rochester | 2019-02-01 |
| An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia (NCT02180724) | Acerta Pharma BV | 2014-09-11 |
Track Waldenström Macroglobulinemia (WM) automatically
Every clearance here is in the API, with alerts when new ones post.